Do you want to read an article? Please log in or register.
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
COVID-19
Related content
Breast Cancer
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
Breast Cancer Res Treat.
Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA
doi: 10.1007/s10549-020-05644-z.
COVID-19
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence
Ecancermedicalscience.
Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M
doi: 10.3332/ecancer.2020.1022.
Lung, Respiratory and Thoracic Cancer
Treatment guidance for lung cancer patients during the COVID-19 pandemic
J Thorac Oncol.
Dingemans AC, Soo RA, Jazieh AR, Rice SJ, Kim YT, Teo LL, Warren GW, Xiao SY, Smit EF, Aerts JG, Yoon SH, Veronesi G, De Cobelli F, Ramalingam SS, Garassino MC, Wynes MW, Behera M, Haanen J, Lu S, Peters S, Ahn MJ, Scagliotti GV, Adjei AA, Belani CP
doi: 10.1016/j.jtho.2020.05.001.
Further Publications
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
Eur J Cancer.
de Joode K, Dumoulin DW, Tol J, Westgeest HM, Beerepoot LV, van den Berkmortel FWPJ, Mutsaers PGNJ, van Diemen NGJ, Visser OJ, Oomen-de Hoop E, Bloemendal HJ, van Laarhoven HWM, Hendriks LEL, Haanen JBAG, de Vries EGE, Dingemans AC, van der Veldt AAM, DOCC Investigators.
doi: 10.1016/j.ejca.2020.09.027.
RECOMMENDED
COVID-19
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
★ 2
Recommended by
Alexander Meisel, Faculty Member
Eur J Cancer.
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, von Bergwelt-Baildon M, Wolf HH, Hirsch HH, Wörmann B, Cornely OA, Köhler P, Schalk E, von Lilienfeld-Toal M
doi: 10.1016/j.ejca.2020.09.009.Visit the original publication at ncbi.nlm.nih.gov
Lung, Respiratory and Thoracic CancerCOVID-19
Severity of COVID-19 in patients with lung cancer: evidence and challenges
J Immunother Cancer
Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S
doi: 10.1136/jitc-2020-002266
COVID-19
Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis
Int J Cancer.
Tian Y, Qiu X, Wang C, Zhao J, Jiang X, Niu W, Huang J, Zhang F
doi: 10.1002/ijc.33213.
COVID-19
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lancet Oncol.
Lee LYW, Cazier JB, Starkey T, Briggs SEW, Arnold R, Bisht V, Booth S, Campton NA, Cheng VWT, Collins G, Curley HM, Earwaker P, Fittall MW, Gennatas S, Goel A, Hartley S, Hughes DJ, Kerr D, Lee AJX, Lee RJ, Lee SM, Mckenzie H, Middleton CP, Murugaesu N, Newsom-Davis T, Olsson-Brown AC, Palles C, Powles T, Protheroe EA, Purshouse K, Sharma-Oates A, Sivakumar S, Smith AJ, Topping O, Turnbull CD, Várnai C, Briggs ADM, Middleton G, Kerr R, UK Coronavirus Cancer Monitoring Project Team.
doi: 10.1016/S1470-2045(20)30442-3.
COVID-19
Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic
JAMA Oncol.
Hartman HE, Sun Y, Devasia TP, Chase EC, Jairath NK, Dess RT, Jackson WC, Morris E, Li P, Hochstedler KA, Abbott MR, Kidwell KM, Walter V, Wang M, Wang X, Zaorsky NG, Schipper MJ, Spratt DE
doi: 10.1001/jamaoncol.2020.5403.